Virginia Retirement Systems Et Al Tricida, Inc. Transaction History

Virginia Retirement Systems Et Al

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.95 - $5.41 $300,200 - $411,160	-76,000 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$4.52 - $7.8 $230,067 - $397,020	50,900 Added 202.79%	76,000 $402,000
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $109,687 - $237,446	25,100 New	25,100 $177,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.